🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a placebo-controlled study evaluating the effects of rosiglitazone ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05-18
Trial ID
NCT00265148
Treatments Being Tested
This was a phase II, randomized, placebo-controlled, double-blind study to ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-10-04
Trial ID
NCT03289143
Treatments Being Tested
N-3 polyunsaturated fatty acids(N-3 PUFAs) is important in balancing the im...
Status
Completed
Location
China Medical University
Start Date
2016-07-07
Trial ID
NCT03542643
Treatments Being Tested
Background: Impairment in cognitive processing speed is a consistent findin...
Status
Completed
Location
Akershus University Hospital, Division of Psychiatry
Start Date
2022-04-04
Trial ID
NCT05211635
This is a Phase 3, multi-center, open-label and randomized withdrawal study...
Status
Enrolling By Invitation
Location
Clinical Research Site
Start Date
2025-02-20
Trial ID
NCT06878976
Treatments Being Tested
Dyspnea is the most reported symptom of patients with advanced Chronic Obst...
Status
Completed
Location
Ciro centre of expertise for chronic organ failure
Start Date
2016-11-16
Trial ID
NCT02429050
Treatments Being Tested
The current study is being conducted by the Sponsor to evaluate the efficac...
Status
Completed
Location
First Choice Neurology - Aventura Neurologic Associates
Start Date
2022-10-05
Trial ID
NCT05189210
Treatments Being Tested
This is a placebo controlled study evaluating the efficacy and safety of me...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
2002-10
Trial ID
NCT00048360
Treatments Being Tested
Other psychiatric disorders, including anxiety, often co-occur with adult A...
Status
Completed
Location
MacAnxiety Research Center
Start Date
2019-04-20
Trial ID
NCT03785223
Treatments Being Tested
This study is evaluating how ruxolitinib affects premalignant breast cells....
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-05-13
Trial ID
NCT02928978
Treatments Being Tested